Akero Therapeutics Inc
NASDAQ:AKRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akero Therapeutics Inc
NASDAQ:AKRO
|
US |
|
K
|
Klepierre SA
SWB:KPR
|
FR |
|
John Wood Group PLC
LSE:WG
|
UK |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
R
|
Regis Corp
F:RGI
|
US |
|
Lindsay Australia Ltd
ASX:LAU
|
AU |
|
Assicurazioni Generali SpA
MIL:G
|
IT |
|
Secom Co Ltd
TSE:9735
|
JP |
|
G
|
General Mills Inc
F:GRM
|
US |
|
O
|
Oracle Corp
DUS:ORC
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
BMV:BBVA
|
ES |
|
Compass Minerals International Inc
NYSE:CMP
|
US |
|
C
|
Case Group AB
F:V9E
|
SE |
|
H World Group Ltd
OTC:HWLDF
|
CN |
|
N
|
NTT Data Corp
XBER:NT5
|
JP |
|
Spire Global Inc
F:43J
|
US |
|
E
|
Energy Recovery Inc
SWB:5E2
|
US |
Bankruptcy Probability
Akero Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akero Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akero Therapeutics Inc
NASDAQ:AKRO
|
4.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akero Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akero Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
